Table 2. Total incidence rate change 1975–2012 and estimated change in diagnoses nationally.
Diagnostic GROUP/Sitea | Male | Female | Total | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Change in ratesb | Change in number of diagnoses | 1975 Rate | Estimated 2012 diagnoses using 1975 rate | 2012 Rate | Estimated 2012 diagnoses | Change in rates | Change in number of diagnoses | 1975 Rate | Estimated 2012 diagnoses using 1975 rate | 2012 Rate | Estimated 2012 diagnoses | Change in rates | Change in number of diagnoses | 1975 Rate | Estimated 2012 diagnoses using 1975 rate | 2012 Rate | Estimated 2012 diagnoses | |
TOTAL | 5.18 | 568 | 18.62 | 2,040 | 23.80 | 2,608 | 4.62 | 480 | 17.77 | 1,847 | 22.39 | 2,328 | 4.91 | 1,050 | 18.20 | 3,887 | 23.12 | 4,936 |
LEUKEMIAS | 0.35 | 38 | 2.67 | 292 | 3.02 | 331 | 0.94 | 98 | 1.54 | 160 | 2.48 | 258 | 0.65 | 138 | 2.11 | 451 | 2.76 | 589 |
Acute lymphoid leukemia | 0.44 | 48 | 1.44 | 158 | 1.88 | 206 | 0.44 | 46 | 0.64 | 66 | 1.08 | 112 | 0.87 | 185 | 0.97 | 208 | 1.84 | 393 |
Acute myeloid leukemia | 0.19 | 21 | 0.74 | 81 | 0.93 | 102 | 0.47 | 49 | 0.58 | 60 | 1.05 | 109 | 0.37 | 80 | 0.64 | 136 | 1.01 | 216 |
LYMPHOMAS | 0.26 | 28 | 5.21 | 571 | 5.46 | 599 | -0.08 | -8 | 4.90 | 510 | 4.82 | 501 | 0.10 | 20 | 5.06 | 1080 | 5.15 | 1,100 |
Non-Hodgkin lymphoma | 0.93 | 102 | 1.55 | 170 | 2.48 | 272 | 0.72 | 75 | 0.83 | 86 | 1.55 | 161 | 0.68 | 145 | 1.21 | 259 | 1.89 | 404 |
Hodgkin lymphoma | -0.68 | -75 | 3.66 | 401 | 2.98 | 327 | -0.81 | -84 | 4.08 | 424 | 3.27 | 340 | -0.98 | -209 | 3.89 | 831 | 2.91 | 622 |
CNS, INTRACRANIAL, INTRASPINAL | 0.21 | 23 | 2.14 | 235 | 2.35 | 258 | 0.31 | 32 | 1.57 | 163 | 1.88 | 195 | 0.26 | 56 | 1.86 | 397 | 2.12 | 453 |
Astrocytoma | -0.20 | -22 | 1.40 | 153 | 1.19 | 131 | 0.06 | 6 | 1.01 | 105 | 1.07 | 112 | -0.07 | -15 | 1.21 | 258 | 1.14 | 243 |
OSSEOUS & CHONDROMATOUS NEOPLASMS | 0.6 | 66 | 1.75 | 192 | 2.35 | 258 | 0.01 | 1 | 1.11 | 115 | 1.12 | 117 | 0.32 | 68 | 1.43 | 306 | 1.75 | 375 |
Osteosarcoma | 0.25 | 27 | 0.94 | 104 | 1.20 | 131 | -0.09 | -9 | 0.63 | 65 | 0.53 | 55 | 0.09 | 19 | 0.79 | 170 | 0.88 | 188 |
SOFT TISSUE SARCOMAS | 0.23 | 25 | 1.43 | 157 | 1.66 | 182 | 0.11 | 11 | 1.39 | 144 | 1.50 | 156 | 0.17 | 37 | 1.41 | 301 | 1.58 | 338 |
GERM CELL AND TROPHOBLASTIC NEOPLASMS | 1.59 | 174 | 2.77 | 304 | 4.37 | 479 | -0.14 | -15 | 1.43 | 149 | 1.29 | 134 | 0.76 | 163 | 2.11 | 451 | 2.87 | 613 |
Testicular/Ovarian | 1.6 | 175 | 2.17 | 238 | 3.77 | 413 | 0.1 | 10 | 1.04 | 108 | 1.14 | 118 | 0.89 | 189 | 1.61 | 344 | 2.50 | 533 |
MELANOMA AND SKIN CARCINOMAS | 0.45 | 49 | 0.96 | 105 | 1.41 | 154 | 0.5 | 52 | 1.63 | 170 | 2.13 | 222 | 0.47 | 101 | 1.29 | 275 | 1.76 | 376 |
Melanoma | 0.43 | 47 | 0.95 | 104 | 1.38 | 151 | 0.52 | 54 | 1.61 | 168 | 2.13 | 222 | 0.11 | 23 | 1.36 | 289 | 1.46 | 312 |
CARCINOMAS (excluding skin) | 1.05 | 115 | 1.44 | 158 | 2.49 | 273 | 2.62 | 272 | 3.83 | 398 | 6.45 | 671 | 1.79 | 383 | 2.62 | 560 | 4.41 | 943 |
Thyroid | 0.39 | 43 | 0.40 | 44 | 0.79 | 87 | 2.57 | 267 | 1.79 | 186 | 4.36 | 453 | 1.12 | 239 | 1.16 | 247 | 2.27 | 486 |
MISCELLANEOUS SPECIFIED NEOPLASMS, NOS | 0.44 | 48 | 0.17 | 19 | 0.62 | 68 | 0.31 | 32 | 0.29 | 30 | 0.60 | 62 | 0.35 | 74 | 0.25 | 54 | 0.60 | 128 |
aClassification scheme for tumors diagnosed in adolescents and young adults (Barr 2006).
bChange in predicted rates calculated from SEER 9 registries, 1975–2012.